US 8337860
Development of dengue virus vaccine components
granted A61KA61K2039/5254A61P
Quick answer
US patent 8337860 (Development of dengue virus vaccine components) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K2039/5254, A61P, A61P31/12, A61P31/14